Flemming Ørnskov
Chairman chez WATERS CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
Le Dr Flemming rnskov est un directeur indépendant de Karo Pharma AB, un directeur général de Galderma Pharma SA, un directeur général de Galderma SA, un président non exécutif de Waters Corp, un président non exécutif d'Astion Pharma A/S, un président de Galderma Holding SA, un directeur général de Shire Pharmaceuticals Ltd. et un président de Bayer HealthCare AG. Il est membre du conseil d'administration de Proactiv Skin Health Ltd, Karo Pharma AB, Centogene AG, de la Chambre de commerce américano-suisse et de la Biotechnology Innovation Organization. Le Dr. rnskov a été précédemment employé en tant que président du conseil de surveillance de Centogene NV, président non exécutif de Recordati SpA, directeur général et directeur non exécutif de Shire Plc, chef de l'unité commerciale mondiale de médecine générale de Bayer Pharma AG, président du conseil de surveillance d'Evotec SE, directeur non exécutif de PCI Biotech Holding ASA, président mondial de la division pharmaceutique et des médicaments en vente libre de Bausch + Lomb, Inc, président non exécutif d'Evotec Neurosciences GmbH, président, président et directeur général de Life Cycle Pharma A/S, président et directeur général d'Ikaria Holdings, Inc. président non exécutif de Roche Innovation Center Copenhagen A/S, analyste des actions du secteur de la santé de Credit Suisse Securities (Europe) Ltd. et membre de Dolder AG, directeur de Merck & Co. /Cherokee Chemical Manufacturing Plant/, président de la Global Ophthalmics Business Unit de Novartis AG, membre du conseil de surveillance de SpePharm Holding BV et président-directeur général de LifeCycle Pharma A/S. Il a obtenu un diplôme d'études supérieures de l'université de Harvard, un MBA de l'INSEAD et un doctorat de l'université de Copenhague.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
WATERS CORPORATION
0,01% | 02/01/2024 | 4 309 ( 0,01% ) | 1 M $ | 31/03/2024 |
CENTOGENE NV
1,08% | 16/05/2023 | 300 000 ( 1,08% ) | 213 000 $ | 31/03/2024 |
Postes actifs de Flemming Ørnskov
Sociétés | Poste | Début |
---|---|---|
WATERS CORPORATION | Chairman | 01/01/2020 |
KARO PHARMA AB (PUBL) | Director/Board Member | 31/10/2019 |
CENTOGENE N.V. | Director/Board Member | 31/12/2020 |
Centogene AG
Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Director/Board Member | - |
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Galderma Pharma SA discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. It offers drugs, medical dermatology solutions, and therapeutic skin care products for treating hair, nail, and skin diseases. The company was founded in 1981 and is headquartered in Lausanne, Switzerland. | Chief Executive Officer | - |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The private company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Chief Executive Officer | - |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Chief Executive Officer | - |
Galderma Benelux BV | Chief Executive Officer | 01/10/2019 |
Proactiv Skin Health Ltd.
Proactiv Skin Health Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Proactiv Skin Health Ltd. is a part of Guthy-Renker Partners, Inc. that provides sales and support services. The private company is based in London, UK. | Director/Board Member | 10/12/2019 |
Anciens postes connus de Flemming Ørnskov
Sociétés | Poste | Fin |
---|---|---|
░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Flemming Ørnskov
INSEAD | Masters Business Admin |
Harvard T.H. Chan School of Public Health | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 9 |
---|---|
WATERS CORPORATION | Health Technology |
BAYER AG | Health Technology |
Health Technology | |
PCI BIOTECH HOLDING ASA | Health Technology |
NOVARTIS AG | Health Technology |
EVOTEC SE | Health Technology |
RECORDATI | Health Technology |
KARO PHARMA AB (PUBL) | Health Technology |
CENTOGENE N.V. | Commercial Services |
Entreprise privées | 21 |
---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Ikaria, Inc.
Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Health Technology |
Credit Suisse Securities (Europe) Ltd.
Credit Suisse Securities (Europe) Ltd. Investment ManagersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Finance |
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Commercial Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Health Technology |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Swiss-American Chamber of Commerce
Swiss-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004. | Commercial Services |
Merck & Co., Inc. /Cherokee Chemical Manufacturing Plant/ | Process Industries |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | Health Technology |
Life Cycle Pharma A/S | |
Dolder AG
Dolder AG Wholesale DistributorsDistribution Services Part of Dolder Bigler AG, Dolder AG is a Swiss company that specializes in producing high-quality plastics and specialty chemicals. The private company is based in Basel, Switzerland and works with other industry leaders such as Coim, Eastman, Evonik, and Huntsman to provide top-of-the-line products for their customers. The company's laripur® tpu and ™ copolyester products are used for injection molding and extrusion, and offer a soft touch effect and higher heat and chemical resistance than other materials. | Distribution Services |
Proactiv Skin Health Ltd.
Proactiv Skin Health Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Proactiv Skin Health Ltd. is a part of Guthy-Renker Partners, Inc. that provides sales and support services. The private company is based in London, UK. | Commercial Services |
Galderma Benelux BV | |
Centogene AG
Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Health Services |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Health Technology |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The private company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Health Technology |